Quebec innovation in the life sciences, supported by players such as IRICoR, plays a vital role in improving the quality of life of patients and makes a significant contribution to meeting the challenges facing the healthcare system.
Read about IRICoR in the special Research section of Le Devoir – BIS.
Among other things, the article highlights the importance of partnerships in overcoming the “valley of death”, a critical gap between basic and clinical research, where financial risks can hamper innovation. It also discusses the need to maintain funding levels in the face of increasingly complex scientific challenges.
To read the article: https://shorturl.at/iDIU1 (only in French)